XML 35 R26.htm IDEA: XBRL DOCUMENT v3.7.0.1
Debt (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Sep. 09, 2016
Mar. 09, 2017
Mar. 09, 2017
Feb. 28, 2017
Feb. 23, 2017
Mar. 31, 2017
Mar. 31, 2016
Dec. 31, 2016
Interest expense           $ 15,350  
Accretion of debt discount           (174,629)  
Estimated volatility               92.00%
Joseph Sierchio [Member] | Loan agreement [Member]                
Interest rate         7.00%      
Maturity date         Feb. 23, 2018      
Convertible debt financing, Loan received         $ 25,000      
Debt instrument terms of conversion feature         (i) $3.45; or (ii) a 20% discount to the average closing price of the Company’s common stock for the five days prior to the date on which the Holder(s) elect to convert the February 2017 Note(s), subject to a floor price of $2.76.      
Joseph Sierchio [Member] | Series F Warrant [Member] | Loan agreement [Member]                
Common stock shares reserved under stock option plan       7,246        
Debt instrument terms of conversion feature       (i) $3.45; or (ii) a 20% discount to the average closing price of the Company’s common stock for the five days prior to the date on which the Holder elects to exercise their Series F Warrant.        
KCC [Member] | Loan agreement [Member]                
Interest expense           12,345    
Accretion of debt discount           131,799    
Convertible debt financing, Maximum amount $ 900,000              
Interest rate 7.00%       7.00%      
Maturity date Dec. 31, 2017       Feb. 23, 2018      
Convertible debt financing, Loan received $ 700,000       $ 395,000      
Convertible debt financing, Remaining amount $ 200,000              
Debt instrument terms of conversion feature (i) $1.54; or (ii) a 20% discount to the average closing price of the Company’s common stock for the five days prior to the date on which KCC elects to convert the Note, subject to a floor price of $1.23.       (i) $3.45; or (ii) a 20% discount to the average closing price of the Company’s common stock for the five days prior to the date on which the Holder(s) elect to convert the February 2017 Note(s), subject to a floor price of $2.76.      
Exercise Price $ 1.25              
Market price of common stock $ 1.54              
Estimated volatility 92.30%              
Risk free interest rate 1.23%              
Expected dividend rate 0.00%              
Expected life 5 years              
Fair value $ 340,735              
Beneficial conversion intrinsic value 359,265              
Debt discount $ 700,000         $ 402,720    
Period for accretion of discount 1.25 years        

The remaining debt discount of $402,720 will be amortized over the next three quarters through December 31, 2017

   
KCC [Member] | Series F Warrant [Member] | Loan agreement [Member]                
Common stock shares reserved under stock option plan       114,493        
Debt instrument terms of conversion feature       (i) $3.45; or (ii) a 20% discount to the average closing price of the Company’s common stock for the five days prior to the date on which the Holder elects to exercise their Series F Warrant.        
KCC [Member] | Series E Warrant [Member] | Loan agreement [Member]                
Common stock shares reserved under stock option plan 584,416              
Debt instrument terms of conversion feature (i) $1.54; or (ii) a 20% discount to the average closing price of the Company’s common stock for the five days prior to the date on which KCC elects to exercise the Series E Warrant.              
February 2017 Loan Agreements [Member] | From February 23, 2017 to March 9, 2017 [Member]                
Interest expense           $ 3,005    
Accretion of debt discount           42,830    
Debt discount           $ 400,456    
Period for accretion of discount          

The remaining debt discount of $400,456 will be amortized over the next four quarters through March 31, 2018

   
February 2017 Loan Agreements [Member] | From February 23, 2017 to March 9, 2017 [Member] | Series F Warrant [Member]                
Common stock shares reserved under stock option plan   128,985 128,985          
Debt instrument terms of conversion feature    

(i) $3.45, the closing price of the Company’s common stock as quoted on the OTCQB on the day prior to issuance of the Warrant; or (ii) a twenty percent (20%) discount to the average closing price of the Company’s common stock as quoted on the OTCQB for the five days prior to the date on which the holder elects to exercise the Warrant

         
February 2017 Loan Agreements [Member] | From February 23, 2017 to March 9, 2017 [Member] | Investor [Member]                
Convertible debt financing, Maximum amount   $ 25,000 $ 25,000          
Interest rate   7.00% 7.00%          
Maturity date   Feb. 23, 2018            
Debt instrument terms of conversion feature  

(i) $3.45, the closing price of the Company’s common stock on the day prior to the issuance of the February 2017 Notes or (ii) a 20% discount to the average closing price of the Company’s common stock for the five days prior to the date on which the Holder(s) elect to convert the February 2017 Note(s), subject to a floor price of $2.76

           
February 2017 Loan Agreements [Member] | From February 23, 2017 to March 9, 2017 [Member] | Investor [Member] | Series F Warrant [Member]                
Common stock shares reserved under stock option plan   7,246 7,246          
Debt instrument terms of conversion feature  

(i) $3.45, the closing price of the Company’s common stock on the day prior to issuance of the Series F Warrant; or (ii) a 20% discount to the average closing price of the Company’s common stock for the five days prior to the date on which the Holder elects to exercise their Series F Warrant

           
February 2017 Loan Agreements [Member] | From February 23, 2017 to March 9, 2017 [Member] | Joseph Sierchio [Member]                
Convertible debt financing, Maximum amount   $ 25,000 $ 25,000          
Interest rate   7.00% 7.00%          
Maturity date   Feb. 23, 2018            
Debt instrument terms of conversion feature  

(i) $3.45, the closing price of the Company’s common stock on the day prior to the issuance of the February 2017 Notes or (ii) a 20% discount to the average closing price of the Company’s common stock for the five days prior to the date on which the Holder(s) elect to convert the February 2017 Note(s), subject to a floor price of $2.76

           
February 2017 Loan Agreements [Member] | From February 23, 2017 to March 9, 2017 [Member] | Joseph Sierchio [Member] | Series F Warrant [Member]                
Common stock shares reserved under stock option plan   7,246 7,246          
Debt instrument terms of conversion feature  

(i) $3.45, the closing price of the Company’s common stock on the day prior to issuance of the Series F Warrant; or (ii) a 20% discount to the average closing price of the Company’s common stock for the five days prior to the date on which the Holder elects to exercise their Series F Warrant

           
February 2017 Loan Agreements [Member] | From February 23, 2017 to March 9, 2017 [Member] | KCC [Member]                
Convertible debt financing, Maximum amount   $ 395,000 $ 395,000          
Interest rate   7.00% 7.00%          
Maturity date   Feb. 23, 2018            
Debt instrument terms of conversion feature  

(i) $3.45, the closing price of the Company’s common stock on the day prior to the issuance of the February 2017 Notes or (ii) a 20% discount to the average closing price of the Company’s common stock for the five days prior to the date on which the Holder(s) elect to convert the February 2017 Note(s), subject to a floor price of $2.76

           
February 2017 Loan Agreements [Member] | From February 23, 2017 to March 9, 2017 [Member] | KCC [Member] | Series F Warrant [Member]                
Common stock shares reserved under stock option plan   114,493 114,493          
Debt instrument terms of conversion feature  

(i) $3.45, the closing price of the Company’s common stock on the day prior to issuance of the Series F Warrant; or (ii) a 20% discount to the average closing price of the Company’s common stock for the five days prior to the date on which the Holder elects to exercise their Series F Warrant